2.1 Health History & Pharmacotherapy Considerations

2.1 Health History & Pharmacotherapy Considerations

Clinical Pearl: The lower extremity functions as a sensitive distal barometer of systemic physiological health. Systemic diseases, nutritional deficits, vascular occlusions, and pharmacological side effects frequently manifest in the feet and toenails long before catastrophic tissue loss occurs. A thorough health history and meticulous medication reconciliation are non-negotiable prerequisites before initiating any mechanical or sharp foot care intervention.

The Structured Health History Interview

Every foot care encounter begins with a focused, structured clinical interview. Because foot care nurses frequently treat older adults and individuals with complex, multi-system chronic illnesses, the interview must systematically capture subjective symptoms while exploring their underlying systemic etiologies.

Chief Complaint (CC) and History of Present Illness (HPI)

The chief complaint should be captured in the patient's own words (e.g., "My toenails are too thick to cut," "I feel like I'm walking on hot coals," or "My shoe is rubbing a spot raw on my little toe"). The nurse then expands this complaint into a comprehensive History of Present Illness using the validated OLDCARTS or OPQRST symptom analysis framework:

• Onset: Did the pain or lesion appear acutely (e.g., following a traumatic walk or new footwear) or develop insidiously over months to years (characteristic of chronic pressure keratoses or onychomycosis)?
• Location: Isolate the exact anatomical region—dorsal, plantar, interdigital, subungual, or periungual. Note whether symptoms are unilateral or bilateral.
• Duration: How long has the current issue persisted? Chronic unhealed lesions lasting longer than two to four weeks require heightened suspicion for malignancy, chronic osteomyelitis, or critical limb ischemia.
• Characteristics: Differentiate the qualitative nature of the sensation. Sharp, stabbing, or aching pain often suggests musculoskeletal strain or structural deformities; burning, lancinating, electrical, or "pins-and-needles" paresthesias point to peripheral neuropathy; deep, boring, throbbing rest pain that worsens with elevation signals severe arterial insufficiency.
• Aggravating and Alleviating Factors: Does pain worsen with weight-bearing or ambulation (biomechanical/musculoskeletal) or improve with standing and dangling the leg over the edge of the bed (ischemic rest pain)? Does elevation alleviate swelling and discomfort (venous disease) or worsen severe pain (arterial disease)?
• Radiation: Does discomfort remain localized to the digit or plantar aspect, or does it radiate proximally up the calf and thigh (radiculopathy, sciatic nerve impingement, or intermittent vascular claudication)?
• Timing and Severity: Score pain on a validated 0–10 scale. Inquire about diurnal variations—morning stiffness that eases after walking indicates plantar fasciitis or rheumatoid arthritis, whereas nocturnal pain that awakens the patient from sleep is a cardinal red flag for ischemic rest pain or painful diabetic neuropathy.

Past Medical and Surgical History (PMSH)

The nurse conducts a targeted systemic review with focused inquiry into conditions known to elevate foot pathology risks:

• Vascular Interventions: Prior lower extremity revascularization procedures, including peripheral bypass grafting (e.g., femoral-popliteal or femoral-tibial bypass), percutaneous transluminal angioplasty (PTA), stenting, or surgical thrombectomy. Inquire about history of deep vein thrombosis (DVT) or superficial venous ablation.
• Amputations and Ulcerations: A history of prior foot ulceration is the single strongest clinical predictor of future re-ulceration, with 5-year recurrence rates exceeding 65%. Any prior partial toe, ray, transmetatarsal, or major limb amputation radically alters biomechanical weight-bearing vectors, shifting high peak plantar pressures onto neighboring osseous structures.
• Orthopedic and Foot Surgeries: Prior bunionectomies, hammer toe corrections, joint fusions (arthrodeses), or Charcot neuroarthropathy reconstructions.
• Cardiovascular and Renal Disease: Presence of coronary artery disease, congestive heart failure (contributing to severe dependent edema), hypertension, and chronic kidney disease or end-stage renal disease (ESRD) requiring hemodialysis.

---

Comprehensive Medication Reconciliation

A thorough medication reconciliation is a vital safety standard. Many patients seen in foot care nursing take complex multi-drug regimens whose physiological effects directly govern the safety of sharp debridement, nail burring, dressing selection, and infection risk.

1. Anticoagulants and Antiplatelet Agents

Patients with atrial fibrillation, mechanical heart valves, venous thromboembolism, or coronary stents are routinely prescribed systemic anticoagulants or antiplatelet therapies:

• Vitamin K Antagonists (Warfarin): Requires monitoring of the International Normalized Ratio (INR). Therapeutic ranges are typically 2.0–3.0 (or 2.5–3.5 for mechanical valves). An INR >3.5 represents supratherapeutic anticoagulation, greatly compounding hemorrhage risk from minor micro-trauma.
• Direct Oral Anticoagulants (DOACs): Direct Factor Xa inhibitors (rivaroxaban [Xarelto], apixaban [Eliquis], edoxaban [Savaysa]) and direct thrombin inhibitors (dabigatran [Pradaxa]). These agents lack routine INR monitoring but confer significant anticoagulant effects with rapid onset.
• Antiplatelet Therapies: Aspirin (81–325 mg), clopidogrel (Plavix), ticagrelor (Brilinta), prasugrel (Effient), and cilostazol (Pletal). Dual antiplatelet therapy (DAPT) poses high risk for prolonged capillary weeping.

Procedural Bleeding Risks and Capillary Bleeding Protocol

During rotary burr nail thinning, manual nipper nail reduction, or conservative sharp debridement of hyperkeratotic calluses, inadvertent nicking of the dermis, nail bed, or periungual sulcus can induce rapid, persistent capillary oozing. The foot care nurse must adhere to a strict, standardized bleeding protocol:

1. Immediate Cessation: Immediately discontinue mechanical burring or sharp trimming upon the first sign of blood or serosanguinous exudate.
2. Direct Continuous Pressure: Apply firm, continuous direct pressure using sterile gauze for a full 10 to 15 minutes by the clock. Never lift or peel back the gauze during this window to check if bleeding has ceased, as doing so dislodges the fragile nascent platelet plug.
3. Limb Elevation: Concurrently elevate the lower extremity above the level of the patient's heart (if tolerated and not contraindicated by severe decompensated heart failure) to decrease hydrostatic venous and capillary pressure.
4. Topical Hemostatic Agents: If capillary oozing continues after 15 minutes of firm pressure, apply a sterile calcium alginate dressing or oxidized regenerated cellulose patch. If permitted by institutional standing orders and physician-approved nursing protocols, chemical cautery with a silver nitrate applicator stick or aluminum chloride solution may be utilized with precision; however, silver nitrate must be restricted strictly to the bleeding focal point to avoid chemical necrosis of healthy periwound skin.
5. Protective Dressing: Apply a sterile, non-adherent contact layer (e.g., silicone or petrolatum gauze) secured with soft conformable gauze. Avoid circumferential rigid tape wrapping that could compromise distal digital arterial perfusion.
6. Documentation and Provider Notification: Document the precise site, estimated blood loss (typically <1–2 mL), duration of pressure applied, hemostatic agents used, and the patient's current anticoagulant regimen. Notify the ordering provider or primary physician if bleeding requires prolonged intervention or if supratherapeutic anticoagulation is suspected.

+-----------------------------------------------------------------------------+
|              CLINICAL PROTOCOL: PROCEDURAL CAPILLARY HEMOSTASIS             |
+-----------------------------------------------------------------------------+
|  Accidental Capillary Nick / Bleeding during Nail Trimming or Debridement   |
|                                     │                                       |
|                                     ▼                                       |
|  [STEP 1: IMMEDIATE CESSATION]                                              |
|  - Cease rotary burr / sharp nipper debridement immediately                 |
|  - Do NOT wipe aggressively or swab with alcohol (delays clotting)          |
|                                     │                                       |
|                                     ▼                                       |
|  [STEP 2: CONTINUOUS DIRECT PRESSURE]                                       |
|  - Apply firm, continuous direct pressure with sterile dry gauze            |
|  - Maintain uninterrupted pressure for 10 TO 15 MINUTES BY THE CLOCK        |
|  - CRITICAL: DO NOT lift or peel gauze to check (dislodges platelet plug)   |
|                                     │                                       |
|                                     ▼                                       |
|  [STEP 3: CONCURRENT LIMB ELEVATION]                                        |
|  - Elevate extremity above the level of the heart to drop hydrostatic head  |
|  - (Verify no severe decompensated congestive heart failure contraindication)|
|                                     │                                       |
|                         Does oozing persist at 15 min?                      |
|                                    / \                                      |
|                             YES   /   \   NO                                |
|                                  /     \                                    |
|  [STEP 4: TOPICAL HEMOSTATIC AGENTS]    [STEP 5: PROTECTIVE DRESSING]       |
|  - Sterile calcium alginate / oxidized  - Apply non-adherent contact layer  |
|    cellulose patch                       (silicone / petrolatum mesh)       |
|  - If permitted by protocol: pinpoint   - Secure with tubular conform gauze |
|    silver nitrate (strictly to vessel)  - NEVER use circumferential tape    |
|                                     │                                       |
|                                     ▼                                       |
|  [STEP 6: CLINICAL DOCUMENTATION & PROVIDER ESCALATION]                     |
|  - Record bleeding site, estimated blood loss (<1-2 mL), pressure duration   |
|  - Note anticoagulant/antiplatelet regimen (check recent INR if on warfarin) |
|  - Escalate to primary care / physician if bleeding refractory >20-30 min   |
+-----------------------------------------------------------------------------+

2. Antidiabetic Pharmacotherapy

Diabetes management involves diverse pharmacological classes with distinct implications for foot care nursing:

• Insulins: Rapid-acting (lispro, aspart), short-acting (regular), intermediate-acting (NPH), and long/ultra-long-acting analogs (glargine, detemir, degludec). Patients injecting pre-prandial insulin who attend clinic appointments during their drug's peak activity without adequate food intake are at high risk for acute intra-visit hypoglycemia.
• Sulfonylureas (Glipizide, Glimepiride, Glyburide): Potent insulin secretagogues known for triggering profound, prolonged hypoglycemic episodes, especially in older adults with declining renal clearance.
• Biguanides (Metformin): The first-line oral agent; does not cause hypoglycemia as monotherapy but poses risks of lactic acidosis in severe renal failure and frequently causes GI disturbances.
• SGLT-2 Inhibitors (Empagliflozin, Dapagliflozin, Canagliflozin): Inhibit renal glucose reabsorption. These agents carry warnings regarding increased risks of mycotic genital infections and rare euglycemic diabetic ketoacidosis (euDKA). Canagliflozin carried a historical black-box warning for lower limb amputations, emphasizing the need for rigorous foot surveillance.
• GLP-1 Receptor Agonists (Semaglutide, Dulaglutide, Liraglutide): Injectable incretin mimetics that slow gastric emptying. While safe from a bleeding standpoint, nausea and delayed gastric absorption can disrupt scheduled carbohydrate intake.

Nursing Vigilance for Hypoglycemia

The certified foot care nurse must recognize early autonomic symptoms of hypoglycemia (blood glucose <70 mg/dL): diaphoresis, paleness, tachycardia, tremors, hunger, anxiety, and lightheadedness. Neuroglycopenic symptoms include confusion, dysarthria, irrational behavior, and somnolence. The clinic must always stock fast-acting simple carbohydrates (15 grams: 4 ounces of fruit juice, 3–4 glucose tablets, or 4 ounces of regular soda) to execute the standard "Rule of 15" (administer 15g carbohydrate, recheck blood glucose in 15 minutes, repeat if still <70 mg/dL).

3. Systemic Corticosteroids and Immunosuppressants

Patients treated with oral corticosteroids (e.g., prednisone 5–40 mg daily) or biologic/disease-modifying antirheumatic drugs (DMARDs: methotrexate, leflunomide; TNF inhibitors: adalimumab, etanercept, infliximab) for rheumatoid arthritis, psoriasis, inflammatory bowel disease, or organ transplants present profound tissue vulnerability:

• Epidermal and Dermal Atrophy: Corticosteroids suppress collagen synthesis, leading to profound skin thinning ("cigarette paper skin"), loss of skin elasticity, and atrophy of the protective subcutaneous fibrofatty plantar pad. Minor shear forces from coarse socks or footwear cause extensive skin tears.
• Capillary Fragility: Dermal capillary support is lost, resulting in widespread senile purpura, ecchymosis, and hematomas following trivial trauma.
• Masked Infection Signs: Systemic immunosuppression blunts the body's inflammatory response. Classic signs of active infection—erythema, local warmth, edema, and purulent drainage—may be severely diminished or entirely absent, presenting deceptively quiet tissue beds even in the presence of invasive bacterial cellulitis or osteomyelitis.
• Impaired Wound Healing: Corticosteroids inhibit fibroblast proliferation, macrophage activation, and angiogenesis, causing significant delays in tissue granulation and re-epithelialization.

4. Neuropathic Pain Modulators

Medications prescribed to alleviate painful diabetic peripheral neuropathy include gabapentinoids (gabapentin [Neurontin], pregabalin [Lyrica]), SNRIs (duloxetine [Cymbalta]), and tricyclic antidepressants (amitriptyline, nortriptyline):

• Therapeutic Goals: Dampen aberrant hyperexcitability in dorsal horn neurons, decreasing burning dysesthesias, shooting pains, and hyperalgesia.
• Adverse Effects and Fall Hazards: These central nervous system modulators frequently induce somnolence, dizziness, ataxia, and psychomotor slowing, significantly escalating fall risks in older adults.
• Peripheral Edema: Gabapentin and pregabalin are notorious for causing dependent lower extremity edema. This fluid accumulation compromises cutaneous barrier function, increases the risk of skin stretching and stasis dermatitis, and alters footwear fit, creating unanticipated focal pressure points over dorsal digits.

5. Over-the-Counter (OTC) Foot Remedies and Dangerous Home Practices

Patients frequently resort to hazardous home treatments and over-the-counter preparations to address foot pain, hyperkeratotic lesions, and thickened nails:

• Caustic Corn and Callus Removal Pads (Salicylic Acid 40%): These ubiquitous drugstore pads contain concentrated keratolytic acids designed to dissolve keratin. However, salicylic acid cannot discriminate between non-viable hyperkeratotic tissue and viable dermis. In patients with sensory neuropathy or peripheral arterial disease, these caustic discs cause extensive full-thickness chemical burns, liquefaction necrosis, secondary polymicrobial infection, and deep ulcerations that rapidly progress to osteomyelitis and limb amputation.
• "Bathroom Surgery": Patients with thickened, fungal nails or painful plantar calluses frequently use unsterilized household tools—such as razor blades, utility knives, sewing needles, craft scissors, or wire cutters—to carve their own lesions. Lacking sterile technique and often compromised by poor eyesight, impaired dexterity, and sensory loss, these individuals inflict severe lacerations and inoculate virulent pathogens into hypoperfused tissue.
• Harmful Soaks and Folk Remedies: Soaking feet in scalding water (often exceeding 110°F/43°C) because insensate feet "feel cold" produces severe full-thickness thermal burns. Harsh chemical soaks with Epsom salts, undiluted bleach, vinegar, or rubbing alcohol cause severe xerosis, cutaneous cracking, and chemical dermatitis. The nurse must firmly educate patients that routine foot soaking is contraindicated in high-risk feet.

---

6. Complementary, Alternative, and Homeopathic Therapies

The blueprint names alternative therapies alongside prescription drugs in the medication history for a reason: patients rarely volunteer them, and several carry direct foot care consequences. Ask explicitly and non-judgmentally — "What vitamins, herbs, supplements, teas, oils, or homeopathic remedies do you take or put on your feet?" — because a patient who has been told to stop "medications" before a procedure will almost never think that includes fish oil.

• Supplements that potentiate bleeding: Fish oil (omega-3), high-dose vitamin E, ginkgo biloba, garlic, ginger, and turmeric/curcumin all have antiplatelet activity. Stacked on top of aspirin, clopidogrel, or an anticoagulant, they meaningfully prolong oozing after nail or callus debridement. Document them, anticipate a longer hemostasis window, and involve the prescriber before any procedure likely to draw blood.
• Topical folk and homeopathic remedies for nails and skin: Tea tree oil, oil of oregano, vinegar or bleach soaks, mentholated chest rub, garlic paste, and urine soaks are widely used for suspected onychomycosis. They are at best weakly effective, and several are irritant or allergenic — tea tree oil and balsam of Peru are common contact-dermatitis triggers. In a neuropathic or ischemic foot, a chemical irritant the patient cannot feel is a wound waiting to happen.
• Soaks of any kind: Epsom salt, vinegar, and herbal soaks are the single most common "harmless" alternative practice in foot care, and they are contraindicated in neuropathy, PAD, and diabetes. Soaking macerates the stratum corneum, strips lipid, opens interdigital fissures, and — in an insensate foot — is a classic route to a scald burn.
• Herb-drug interactions that matter systemically: St. John's wort induces CYP3A4 and reduces the levels of many drugs; cinnamon, chromium, bitter melon, and alpha-lipoic acid can potentiate hypoglycemia in a patient already on insulin or a sulfonylurea; licorice root aggravates hypertension and edema.
• Documentation and framing: Record the product, dose, route, frequency, and the patient's reason for using it. Then correct only what is unsafe. Dismissing a culturally rooted remedy outright usually means the patient keeps using it and stops telling you — which is the worst of both outcomes. Substitute a safe equivalent (a urea-based emollient instead of a caustic soak) and explain the specific mechanism of harm.

---

Medication Risk and Clinical Action Matrix